Collection of urines. The subjects were given various nicotinyl compounds (Table 1 ) in turn at weekly intervals, together with 400 ml. of water, and their urines were collected for 3 hr. The dose was administered after breakfast, except in the case of the second dose of nicotinic acid which was given before breakfast to induce maximum flushing of the skin.
The control urines from the undosed subjects were collected in the same way after giving 400 ml. of water. The urines were stored at 40 under toluene.
Rats
Sixteen male piebald rats, weighing 55-60 g., were divided into two groups and housed in individual cages. One group received the low-protein maize diet of Harris & Kodicek (1950) , which is deficient in nicotinic acid, and the other group received an adequate synthetic diet containing 18% casein.
Low-prote.in maize diet (Harris & . Casein (Genatosan, vitamin-free) 3-5, sucrose 51-4, maize meal 40; salt mixture 3 , cotton-seed oil 2, cystine 0-1.
Synthetic casein diet. Casein (Genatosan, vitamin-free) 18, sucrose 73-85, salt mixture 5, cotton-seed oil 3, cystine 0-15. Each kg. of diet also contained: choline chloride 2 g., thiamine 3 mg., riboflavin 3 mg., pyridoxin 3 mg., calcium D-pantothenate 20 mg., biotin 0-1 mg.
In addition, each rat received per 08, once a week, 0-5 mg. tocopherol acetate, 0-1 mg. 2-methyl-1:4-naphthaquinone and 0-1 g. Radiostoleum (British Drug Houses Ltd.) containing 1500 i.u. vitamin A and 300 i.u. vitamin D.
The rats were maintained on these diets for 19 days during which time the deficient group on the low-protein maize diet gradually decreased in weight. At the end of this period they were transferred to metabolism cages. Two rats were placed in each cage and their urines were collected for 48 hr. while they were maintained on the diets. The animals were then given various nicotinyl compounds, listed in Table 2 , on palettes for 2 days and the urines were again collected.
Estimation of nicotinyl compounds
Total alkali-hydrolysable tertiary nicotinic acid derivativqs, which include nicotinic acid, nicotinamide and nicotinuric acid (nicotinylglycine), were estimated chemically according to the method of Wang & Kodicek (1943) . The estimation of N'-methylnicotinamide was carried out bythe method . In view of certain differences between the chemical and chromatographic data, human urines (see Table 1 ) were also studied by using the microbiological procedure of Clegg, Kodicek & Mistry (1952) . Chromatograms of the urine from an undosed subject (no. 2) were also tested microbiologically by using a technique similar to that described by Leifer, Langham, Nyc & Mitchell (1950) . These estimations were kindly carried out by Miss K. M. Clegg. Separation of nicotinyl compounds in urines by paper chromatography and their estimation
The chromatographic procedures for the separation of tertiary and quaternary nicotinyl compounds (Kodicek & Reddi, 1951) were applied to urines, and the concentrations of the tertiary nicotinyl substances were evaluated by visual Vol. 53 METABOLISM OF comparison of the coloured spots by a procedure similar to that described by Berry, Sutton, Cain & Berry (1951) .
Procedure. 10 ml. of urine were evaporated to dryness under reduced pressure at 55-60o. The residue was extracted with 1 ml. of distilled water and centrifuged. The clear supernatant was used for chromatographic studies, in which 10pl. were placed on Whatman filter paper no. 1 and descending chromatograms were run overnight. In some cases, where the quantity of substance to be detected was very low, four spots of 10pl. each were placed one over the other after drying each spot thoroughly. Pure nicotinyl compounds, in amounts ranging from 0-1 to 2-0 tg., were run on the same paper along with the urines. Tertiary nicotinyl compounds. For these compounds nbutanol saturated with water was found to be the best solvent system. After development, the papers were dried at room temperature. The dry papers were placed in a closed glass tank for 1 hr. at room temperature over CNBr, prepared according to the method of Wang & Kodicek (1943) . They were then sprayed with 2% p-aminobenzoic acid (2 g. ofp-aminobenzoic acid dissolved in 75 ml. 0-75N-HCI andmadeuptolO0ml. with96 % ethanol). The different compounds could be identified by their colours and B.
values (Kodicek & Reddi, 1951) . All the spots fluoresced bright yellow under ultraviolet light, and quantities as low as 0-1 Ag. could be detected under these conditions. Since within a range of 0-1-2-0jg. the area of the spots remained the same, the gradation of the colour intensity, especially when viewed in ultraviolet light, allowed a fairly accurate comparison with the standards. The most suitable concentration for evaluation was within the range of 0-250--5,ug., and by averaging the estimates of two independent observers a difference of 0-1 lAg. could be detected. Duplicate chromatograms sprayed only with the p-aminobenzoic acid reagent, without exposing them to CNBr, served as controls to eliminate non-specific colour spots which were found to be present both in dosed and undosed urines. In the present studies it was not found necessary to adjust the pH of the urinary concentrate to neutrality, since the B, values of the metabolites corresponded well with those reported earlier on pure substances (Kodicek & Reddi, 1951 (Fig. 1 ).
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3-Hydroxyanthranilic acid and kynurenic acid were identified by running pure samples on the same papers. Tryptophan and kynurenine were identified by spraying with the p-dimethylaminobenzaldehyde reagent (0-5 g. p-dimethylaminobenzaldehyde, 1 ml. conc. HC1 and 100 ml. absolute ethanol), and by their behaviour on exposure to vapours of conc. HCl (Tabone, Robert, Thomassay & Mamounas, 1950) . The RF values of other metabolites were compared with those reported by Dalgliesh, Knox & Neuberger (1951) .
RESULTS

Man
The urines from undosed subjects, collected for a period of 3 hr., contained 0-5-0-6 mg. of Nl-methylnicotinamide, with an average of 0-53 mg. (Table 1 ). The total content of tertiary aLkali-hydrolysable derivatives of nicotinic acid, as determined chemically, ranged from 0-2 to 0-3 mg. within the 3 hr. period. However, no tertiary nicotinyl derivatives could be detected on chromatograms. In view of this discrepancy, microbiological estimations were carried out on urinary concentrates hydrolysed with N-sodium hydroxide. The microbiological values (Table 1) were much lower than those determined chemically, ranging from 0-04 to 0-12 mg. of nicotinic acid/3 hr. Similar results were obtained when the urines were tested without a prior alkaline hydrolysis.
When urine from undosed subjects, concentrated 10 times, was chromatographed and the strips were analysed microbiologically for nicotinic acid activity, according to the procedure of Leifer et al. (1950) , the B, region corresponding to nicotinamide showed some activity. The concentration of nicotinamide amounted to 40 % of the total nicotinic acid derivatives as determined microbiologically. The rest of the activity remained at the place of application of the spots (40 1p.) and spread to a distance of 3 cm. from the origin. Dosing writh nicotinic acid. After doses of 100 mg. nicotinic acid the excretion of alkali-hydrolysable nicotinic acid derivatives and of Nl-methylnicotinamide increased to 6-0-14-6 mg. and 2-8-5-7 mg./ 3 hr., respectively ( Table 1 ). The chromatographic results showed that the major metabolite in the urines was nicotinuric acid, forming 92-99 % of the alkali-hydrolysable derivatives; the rest could be accounted for by a small amount (1-4%) of nicotinamide.
There was no free nicotinic acid in the urines except in one subject (no. 3) who had intense flushing of the skin soon after the ingestion of nicotinic acid. This individual had, incidentally, the highest excretion of tertiary nicotinyl compounds and the lowest of Nl-methylnicotinamide. The vasodilatory effect ofnicotinic acid, especially when taken ante-prandially, is well known. It was of interest to verify whether the appearance of free Tryptophan metabolites. When 10 times concentrated urines, obtained after dosing with tryptophan, were chromatographed using n-butanol-acetic acid-water (40:10:50), a number of tryptophan metabolites could be identified by their fluorescence and also by spraying with the p-dimethylaminobenzaldehyde reagent (Fig. 1) . Spots 4 and 6 were identified as kynurenic acid and 3-hydroxyanthranilic acid, respectively, by running the pure substances side by side on the same paper. Spot 3 was identified as kynurenine. It corresponded to the spot F (kynurenine) of Dalgliesh et al. (1951 Dosing with nicotinic acid. After dosing with 2-5 mg. nicotinic acid, the deficient rats excreted 37 % and the normal animals 90 % of the dose in the form of Nl-methylnicotinamide, nicotinuric acid, nicotinic acid and nicotinamide. In the deficient animals, the major excretion products, NL-methylnicotinamide and nicotinuric acid, were in equal proportions, each being about 16% of the dose. There was a definite rise in the excretion of nicotinic acid, but only a small rise in nicotinamide, about 3-5 and 0-3 % of the dose respectively. In the normal animals, the main excretion products in descending order were Nl-methylnicotinamide 41 %, nicotinuric acid 23 %, nicotinic acid 12-2 %, and nicotinamide 2-5 % of the dose (Fig. 2 ). As will be seen from Table 2 ( Table 2 ). The major excretion product was N'-methylnicotinamide, forming in the deficient group 40 % and in the normal group 70 % of the dose. 
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Nicotinamide was excreted in significant amounts, namely 8 % of the dose in the deficient animals and 18 6 % in the normal rats. The excretion of nicotinic acid was only about 2*5 and 4-6% of the dose respectively (Fig. 2) . Do8ing with quinolinic acid. After dosing with 100 mg. quinolinic acid the deficient animals showed no rise in the excretion of N'-methylnicotinamide, and an insignificant increase in the tertiary nicotinyl compounds. The distribution of nicotinic acid and amide was the same as in urine obtained before dosing, namely 46 and 56%. In the normal group the excretion of NI-methylnicotinamide increased from 0-24 to 0 57 mg. and that of the tertiary nicotinyl compounds rose from 0 04 to 0 14 mg./day/rat. This rise was mainly due to an increased excretion of nicotinic acid, which formed 86% of the total tertiary nicotinyl compounds (Table 2) . Do8ing with L-tryptophan. After dosing with 100 mg. L-tryptophan, there was, in the deficient rats, a slight increase in the excretion of N'-methylnicotinamide and of tertiary nicotinyl compounds. A similar but more pronounced rise of these substances was found in the normal group. The increase in the tertiary nicotinyl compounds, both in the deficient and normal rats, was mainly due to a rise in nicotinic acid, which formed in the deficient group 71 % and in the normal rats 90 %. of these derivatives (Table 2) .
DISCUSSION
The paper-chromatographic technique used for partitioning nicotinic acid derivatives, besides being simple and easily performed, has many advantages over the chemical methods employed by earlier workers (Melnick et al. 1940; Perlzweig et al. 1940 ; Huff & Perlzweig, 1941) . Especially in the case of the tertiary nicotinyl compounds, the estimations based on Konig's colour reaction may be interfered with by unspecific colour formation in the urines which has to be corrected by the use of proper blanks. In the chromatographic procedure, one compares the colour of pure compounds separated on the chromatograms and thus eliminates errors due to interference by other substances. It was found advantageous to spray a duplicate chromatogram with the p-aminobenzoic acid reagent alone, without the cyanogen bromide treatment, and to distinguish in this way several coloured nonspecific spots which usually appear on the chromatograms. One other advantage of the procedure is the possibility of employing it in elucidating the fate of ingested nicotinyl compounds in man, where one could not easily use radioactive substances employed successfully in the rat (Johnson & Lin, 1951; Leifer et al. 1951 ). The method is sufficiently sensi- METABOLISM OF NICOTINIC ACID tive to detect amounts of importance, although in certain cases one has to take recourse to the more sensitive microbiological technique (Leifer et al. 1950 ), as will be discussed below. One drawback of the method is that it could not be used for the detection of N1-methyl-2-pyridone-5-carbonamide which is of particular importance in human urines. Furthermore, the method does not detect quinolinic acid.
The fluorescent procedure for detecting quaternary nicotinyl compounds is highly sensitive and would allow the differentiation of a number of compounds besides N'-methylnicotinamide, should they appear in the urines. It is interesting that in no case could any other quaternary nicotinyl derivative, such as the pyridine nucleotide coenzymes or Nl-methylnicotinuric acid betaine, be found.
Metabolites in normal urine
In urine from undosed human subjects, no nicotinyl compound other than NT-methylnicotinamide could be detected on the chromatograms. The high values of the total alkali-hydrolysable nicotinyl derivatives obtained. by chemical methods may have been due to interfering substances which the blank did not correct. This is supported by the relatively low values found microbiologically. No such interference in the chemical method was found in the urines after dosing because of the small amount of urine used for assay. The analysis of chromatograms by the microbiological procedure showed the presence of a small amount of nicotinamide, of the order of 0-075 g./ml. of urine. This concentration was below that detectable by the spraying procedure. The rest of the microbiological activity remained at the origin of the chromatograms and we were unable to identify these unknown active substances. Since large amounts of urine concentrate had to be applied to the paper to obtain a satisfactory microbiological response, and since the original spots spread to the region where normally nicotinuric acid appears, we could not eliminate the possibility of an occurrence of small amounts of nicotinuric acid; however, no nicotinic acid seemed to be present. Perlzweig et al. (1940) and Sarrett et al. (1942) reported the presence of small amounts of nicotinuric acid, while Melnick et al. (1940) could not find any in normal urine. Ellinger & Kader (1949) reported the presence of both nicotinic acid and nicotinamide. These discrepancies may be due to defects inherent in chemical methods.
In contrast to the human urines, the urines both of the nicotinic acid-deficient and normal rats, which were not given any doses, contained detectable amounts of nicotinic acid and nicotinamide, in addition to small amounts of Nl-methylnicotinamide. These metabolites were present in a significantly higher concentration in the normal group.
Metabolites of nicotinic acid
The ingestion of nicotinic acid by man is followed within the first 3 hr. by the excretion of a glycine conjugate, nicotinuric acid, and of the NL-methylated nicotinyl derivatives, of which N'-methylnicotinamide could be detected in these studies. It is interesting to find a small rise in the excretion of nicotinamide, ir licating not only that amidation has taken place, but also that a portion of this metabolite is being lost to the organism. It appears from our results that free nicotinic acid is not a normal constituent in the human urine after dosing, but is found only under certain conditions, associated with the known pharmacological effects of this compound. It seems that it is due to a sudden occurrence in the organism of a high concentration of nicotinic acid which cannot be dealt with satisfactorily by the normal metabolic mechanisms. The large excretion of nicotinic acid was particularly pronounced when the dose was taken on an empty stomach. It seems probable that the liver is mainly concerned -with the formation of the glycine conjugate, and if it cannot perform this function free nicotinic acid circulating in the blood causes the vasodilatory symptoms and is ultimately excreted in the urine. The appearance of free nicotinic acid in the urine may possibly be a test for the efficiency of liver function, although the effect on the vessels of the kidney may be a complicating factor. A distribution of metabolites similar to that in man was found in the rat, but in this case nicotinic acid appeared consistently in appreciable amounts in the urines. This may have been due to the relatively large dose administered to the animals. The deficient animals excreted a smaller amount of nicotinyl metabolites than the normal group, but the excretion pattern did not change. It would be of interest to see if similar results were obtained in human deficiency.
Our results on human urines are in keeping with those of Holman & de Lange (1950a) who found that ingestion of nicotinic acid resulted in a greater excretion ofnon-methylated derivatives ofnicotinic acid than after ingestion of nicotinamide. In either instance 76-80 % ofthe dose could be accounted for, when the excretion of Nl-methyl-2-pyridone-5-carbonamide was included. The presence of free nicotinic acid in the urines of individuals dosed with nicotinic acid, was reported by Ellinger & Kader (1949) who, on the other hand, could not find in hulman and rat urines any nicotinuric acid which in our studies formed the main excretory product. Our results on rat urines are in good agreement with those of Johnson & Lin (1951) and Leifer et al. (1951) who fed radioactive nicotinic acid to rats.
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VoI. 53 291 K. K. REDDI AND E. KODICEK MetaboliteB of nicotinamide The spectrum of metabolites appearing in human urines after dosing with nicotinamide was different from that found after ingestion of nicotinic acid. N'-Methylnicotinamide appeared to be the major excretion product after dosing with nicotinamide, but we have no data for NI-methyl-2-pyridone-5-carbonamide which is known to be an important mnetabolite (Knox & Grossman, 1946 Holman & de Lange, 1949 Perlzweig, Rosen & Pearson (1950) , reported the presence of nicotinuric acid in rat urines after dosing with *nicotinamide.
While only 50 % of the dose of nicotinamide appeared in urines of deficient rats, almost the entire dose was recovered in the normal animals, the major part as N1-methylnicotinamide. Similarly, a higher proportion of the dose of nicotinic acid was excreted by the normal than the deficient group. It would appear that in the presence of sufficient dietary tryptophan the rat either has preference for the tryptophan-nicotinic acid conversion or the ingestion of nicotinyl compounds may influence favourably this conversion of tryptophan. This may be the reason why in normal rats such a high recovery of the dose of nicotinic acid or amide was observed. This is in agreement with the findings of Spector (1948) .
Metabolites of L-tryptophan
In man, after ingestion of tryptophan, an increased excretion of N1-methylnicotinamide was found, but not of other nicotinyl derivatives. Similar observations were earlier reported by Sarrett & Goldsmith (1947 and by Sarrett (1950a) . Perlzweig, Rosen, Levitas & Robinson (1947) observed by microbiological methods a small increase in the excretion of nicotinyl compounds. The excretion ofNl-methyl-2-pyridone-5-carbonamide, which rises significantly after administration of tryptophan (Holman & de Lange, 1950b) , and of quinolinic acid, which forms a major excretion product in rats (Henderson, 1949a) , and in man (Sarrett, 1950a) , was not determined since these substances could not be identified on paper chromatograms with the present procedures.
In the rat, possibly due to its more efficient conversion of tryptophan to nicotinic acid, there was a small but definite increase in the excretion of nicotinic acid, while that of nicotinamide did not rise. This was the case both in the deficient and normal rats, but the latter excreted more of the nicotinyl metabolites than the deficient ones. The finding of nicotinic acid rather than the amide could be taken as circumstantial evidence that tryptophan is converted primarily into nicotinic acid. This is in keeping with the conclusions of Heidelberger, Abraham & Lepkovsky (1948 who showed the' conversion by rats of labelled tryptophan into N.-methylnicotinamide. Sarrett (1950a, b) found an increase in the excretion of xanthurenic acid (4:8-dihydroxyquinoline carboxylic acid) in man after administration of tryptophan and of an ether-soluble tryptophanlike metabolite which seemed to be derived from D-tryptophan (Sarrett & Goldsmith, 1950) . So far as we are aware, no other metabolites have been reported in the urineofhumans dosedwithtryptophan. In the present study, 3-hydroxyanthranilic acid, kynurenic acid and kynurenine have been found in the human urines. It seems, therefore, that the conversion of tryptophan in man follows the same pathway as was found for the rat (Heidelberger et al. 1949 ). An appearance of tryptophan in the urines was not unexpected, but there were several other tryptophanmetaboliteswhich couldnotbe definitely identified. It was only possible to compare them with published paper-chromatographic data recently reported by Dalgliesh et al. (1951) and there is not sufficient evidence for a definite identification.
Metabolites of quinolinic acid Dosing with large amounts of qumiolinic acid in normal rats resulted in an increased excretion of N'-methylnicotinamide and ofnicotinic acid. This is in keeping with the findings of Henderson (1949a, b) and would indicate that the rat can convert quinolinic acid into nicotinic acid. However, no such effect was observed in deficient rats, but the declining growth of the rats was reversed and they increased in weight by 17 g. within 13 days after a single dose of 100 mg. quinolinic acid. It is possible 292 I953 that the conversion into nicotinic acid was of such low order that all the vitamin was retained by the deficient animal and none was available for excretion. We would agree with Krehl, Bonner & Yanofsky (1950) that the metabolism of quinolinic acid is of the order of a side reaction rather than forming a keystone in the nicotinic acid turnover. SUMMARY 1. The excretion of metabolites by man and the rat after administration of nicotinic acid, nicotinamide and tryptophan has been studied by paperchromatographic techniques. The procedure did not allow for the detection of Nl-methyl-2-pyridone-5-carbonamide.
2. After a dose of 100 mg. nicotinic acid to man, the main nicotinyl metabolites in the urine were, in decreasing order, nicotinuric acid, N'-methylnicotinamide and nicotinamide. Nicotinic acid appeared in the urine only when flushing of the skin and other vasodilatory symptoms occurred. In the rat, nicotinic acid appeared consistently in the urines, but otherwise the pattern of excretion remained the same as in man.
3. The administration of 100 mg. nicotinamide to human subjects caused only an increased excretion of Nl-methylnicotinamide and of nicotinamide. Rat urine contained, in addition, an increased amount of nicotinic acid. Nicotinuric acid was not excreted by either of the species.
4. After ingestion of 3 g. L-tryptophan, human urines showed an increase in the excretion of Nlmethylnicotinamide, while rat urines had in addition an increased output of nicotinic acid. In human urines, a number of tryptophan metabolites, namely kynurenic acid, 3-hydroxyanthranilic acid, kynurenine and tryptophan, were identified. 5. Administration of 100 mg. quinolinic acid to normal rats resulted in an increased excretion of N'-methylnicotinamide and nicotinic acid, while rats deficient in nicotinic acid showed no such rise.
6. The differences in the excretion patterns between nicotinic acid-deficient and normal rats after dosing with the various substances have been discussed.
7. In urines from undosed human subjects, microbiological techniques instead of the chemical procedure had to be used to detect on chromatograms the tertiary nicotinyl compounds because of the small amounts of nicotinyl derivatives present. The urines contained a small amount of nicotinamide and of NI-methylnicotinamide. Urines from undosed rats, both deficient and normal, contained Nl-methylnicotinamide, nicotinamide and nicotinic acid.
